Clinical Trial Update: rhuFVIIa in Post-partum Hemorrhage [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating recombinant human factor VIIa for postpartum hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• NovoSeven (recombinant coagulation factor VIIa)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Postpartum Hemorrhage | Phase 4 | Status: COMPLETED